Not applicableUnknownNCT04109300
What this trial is testing
Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease
Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
Western University, Canada 162